This Article Full Text Full Text (PDF) All Versions of this Article: 110/2/135    most recent 01.CIR.0000134956.96543.4Fv1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Togni, M. Articles by Hess, O. M. Search for Related Content PubMed PubMed Citation Articles by Togni, M. Articles by Hess, O. M. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Exercise for Children Exercise for Seniors Exercise and Physical Fitness Hazardous Substances DB NITRIC OXIDE NITROGLYCERIN Related Collections Coronary circulation Restenosis Catheter-based coronary and valvular interventions: other Catheter-based coronary interventions: stents

(Circulation. 2004;110:135-140.)
© 2004 American Heart Association, Inc.

Original Articles

Deleterious Effect of Coronary Brachytherapy on Vasomotor Response to Exercise

Mario Togni, MD; Stephan Windecker, MD; Peter Wenaweser, MD; David Tueller, MD; Abudukadier Kaisaier, MD; Willibald Maier, MD; Bernhard Meier, MD; Otto M. Hess, MD

From the Swiss Cardiovascular Center, Inselspital, Switzerland.

Correspondence to Otto M. Hess, MD, FAHA, Swiss Cardiovascular Center, Inselspital, CH-3010 Bern, Switzerland. E-mail otto.martin.hess{at}insel.ch

Received September 3, 2003; de novo received December 19, 2003; revision received March 16, 2004; accepted March 19, 2004.

Background— Intracoronary radiotherapy (brachytherapy) has been proposed as treatment option for in-stent restenosis. Long-term results of brachytherapy with regard to vascular integrity and vasomotor responsiveness are unknown. The purpose of the present study was to determine the vasomotor response after brachytherapy and to assess its influence on vasomotion during exercise.

Methods and Results— Biplane quantitative coronary angiography was performed at rest and during bicycle exercise in 27 patients with coronary artery disease. Fourteen patients underwent coronary stenting and were studied 10±3 months after intervention (control group). Thirteen patients were treated with brachytherapy (Guidant Galileo System) for in-stent restenosis with a mean dosis of 20 Gy at 1 mm into the vessel wall and were studied 9±1 months after radiation (brachytherapy group). Minimal luminal area, stent area, and proximal, distal, and a reference vessel area were determined. The reference vessel showed exercise-induced vasodilation (26±4%, P<0.001) in both groups. Vasomotion within the stented vessel segments was abolished. In control subjects, the proximal and distal segments showed exercise-induced vasodilation (17±2% and 22±7%, respectively; P<0.005). In contrast, there was exercise-induced vasoconstriction in the proximal and distal vessel segments of the brachytherapy group (–14±3% and –16±4%, respectively; P<0.01). Sublingual nitroglycerin was associated with maximal vasodilation of the proximal and distal vessel segments in both groups.

Conclusions— Normal vessel segments elicit flow-mediated vasodilation during exercise. Stent implantation does not affect physiological response to exercise proximal and distal to the stent. Brachytherapy eliminates exercise-induced vasodilation, although dilatory response to nitroglycerin is maintained, suggesting endothelial dysfunction as the underlying mechanism.

Key Words: stents • restenosis • exercise • vasodilation • vasoconstriction

This article has been cited by other articles:

				K. Tanaka, M. Sata, T. Natori, J.-r. Kim-Kaneyama, K. Nose, M. Shibanuma, Y. Hirata, and R. Nagai Circulating progenitor cells contribute to neointimal formation in nonirradiated chimeric mice FASEB J, February 1, 2008; 22(2): 428 - 436. [Abstract] [Full Text] [PDF]

				M. Togni, S. Eber, J. Widmer, M. Billinger, P. Wenaweser, S. Cook, R. Vogel, C. Seiler, F. R. Eberli, W. Maier, et al. Impact of Vessel Size on Outcome After Implantation of Sirolimus-Eluting and Paclitaxel-Eluting Stents: A Subgroup Analysis of the SIRTAX Trial J. Am. Coll. Cardiol., September 18, 2007; 50(12): 1123 - 1131. [Abstract] [Full Text] [PDF]

				S. Wheatcroft, J. Byrne, M. Thomas, and P. MacCarthy Life-Threatening Coronary Artery Spasm Following Sirolimus-Eluting Stent Deployment J. Am. Coll. Cardiol., May 2, 2006; 47(9): 1911 - 1912. [Full Text] [PDF]

				S. Windecker, A. Remondino, F. R. Eberli, P. Juni, L. Raber, P. Wenaweser, M. Togni, M. Billinger, D. Tuller, C. Seiler, et al. Sirolimus-Eluting and Paclitaxel-Eluting Stents for Coronary Revascularization N. Engl. J. Med., August 18, 2005; 353(7): 653 - 662. [Abstract] [Full Text] [PDF]

				M. Togni, S. Windecker, R. Cocchia, P. Wenaweser, S. Cook, M. Billinger, B. Meier, and O. M. Hess Sirolimus-Eluting Stents Associated With Paradoxic Coronary Vasoconstriction J. Am. Coll. Cardiol., July 19, 2005; 46(2): 231 - 236. [Abstract] [Full Text] [PDF]

				R. Serry and W. F. Penny Endothelial Dysfunction After Sirolimus-Eluting Stent Placement J. Am. Coll. Cardiol., July 19, 2005; 46(2): 237 - 238. [Full Text] [PDF]

				P. Erne, P. Jamshidi, P. Juelke, H.-P. Hafner, P. Thum, and T. Resink Brachytherapy: Potential therapy for refractory coronary spasm J. Am. Coll. Cardiol., October 6, 2004; 44(7): 1415 - 1419. [Abstract] [Full Text] [PDF]